Trials / Sponsors / Innovent Biologics Technology Limited (Shanghai R&D Center)
Innovent Biologics Technology Limited (Shanghai R&D Center)
Industry · 7 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Tigulixostat (IBI128) vs Febuxostat in Gout Gout | Phase 3 | 2026-03-17 |
| Recruiting | This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Soli Solid Tumor | EARLY_Phase 1 | 2026-01-29 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD Neovascular Age-related Macular Degeneration | Phase 2 | 2025-12-05 |
| Active Not Recruiting | A Study of IBI3032 in Chinese Participants With Overweight or Obesity Overweight or Obesity | Phase 1 | 2025-09-25 |
| Recruiting | A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity Part A: Healthy Part B: Overweight or Obesity | Phase 1 | 2025-09-04 |
| Completed | A Study of IBI3032 in Chinese Healthy Subjects Healthy | EARLY_Phase 1 | 2025-08-29 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME） Diabetic Macular Oedema | Phase 2 | 2025-04-24 |